Log in
Enquire now

List of CLOUDBREAK THERAPEUTICS LLC patents

List of CLOUDBREAK THERAPEUTICS LLC patents
List of Tribune Media patents
List of Salk Institute for Biological Studies patents
List of CFD Research Corporation patents
List of funding rounds for Madison Reed, Inc.
List of companies in Providence Strategic Growth's investment portfolio
Patents where
Current Assignee
Name
is
CLOUDBREAK THERAPEUTICS LLCCLOUDBREAK THERAPEUTICS LLC
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10980741 Compositions and methods for treating pterygium recurrence

Patent 10980741 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on April, 2021 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
10980741
April 20, 2021
‌
US Patent 9987223 Compositions and methods for treating pterygium

Patent 9987223 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on June, 2018 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
9987223
June 5, 2018
‌
US Patent 9980901 Compositions and methods for treating pterygium

Patent 9980901 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on May, 2018 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
9980901
May 29, 2018
‌
US Patent 10335408 Compositions and methods of using nintedanib for improving glaucoma surgery success

Patent 10335408 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on July, 2019 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
10335408
July 2, 2019
‌
US Patent 10149820 Compositions and methods for treating pterygium

Patent 10149820 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on December, 2018 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
10149820
December 11, 2018
‌
US Patent 10688092 Compositions and methods of using nintedanib for improving glaucoma surgery success

Patent 10688092 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on June, 2020 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
10688092
June 23, 2020
‌
US Patent 11007214 Compositions and methods for treating eye diseases

Patent 11007214 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on May, 2021 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
11007214
May 18, 2021
‌
US Patent 10744153 Compositions and methods for treating meibomian gland dysfunction

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
10744153
August 18, 2020
‌
US Patent 10149819 Compositions and methods for treating hyperemia

Patent 10149819 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on December, 2018 by the United States Patent and Trademark Office.

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
10149819
December 11, 2018
‌
US Patent 11666533 Emulsion formulations of multikinase inhibitors

CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
United States Patent and Trademark Office
United States Patent and Trademark Office
11666533
June 6, 2023
10 results
0 selected
10 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us